From: What has changed in kidney transplantation in small islands in Japan? Experience in our center
| Mean (n = 25) | |
|---|---|
| Recipient factors | |
| Age at kidney transplantation (years) | 56.3 ± 11.39 |
| Gender (M/F) | 15/10 |
| The recipient diseases leading to ESRD | |
| Diabetes mellitus | 9 (36.0%) |
| Chronic glomerulonephritis | 7 (28.0%) |
| ADPKD | 3 (12.0%) |
| RPGN | 2 |
| Nephrosclerosis | 1 |
| Unknown | 1 |
| Mean dialysis duration pre-transplantation 382.6 ± 233.2 days. (preemptive: 4 cases) | |
| Donor factors | |
| Age at donation (years) | 57.9 ± 8.48 |
| Gender (M/F) | 14/11 |
| Relation | |
| Father | 2 |
| Brother | 6 |
| Sister | 2 |
| Husband | 4 |
| Wife | 8 |
| Children | 2 |
| Transplantation factors | |
| Living/deceased donor | 24/1 |
| ABO (com/incom/mm) | 11/9/5 |
| Living/deceased donor (n) | 24/1 |
| HLA-AB mismatches | 2.00 |
| HLA-DR mismatches | 1.14 |
| Immunosuppression | |
| Tacrolimus/cyclosporine (n) | 21/4 |
| Mycophenolate mofetil (n) | 20 |
| Mizoribine/Azathioprine | 3/1 |
| Basiliximab/rituximab (n) | 23/15 |